JPRN-UMIN000025398招募中2 期
A phase 2 trial of nab-paclitaxel, oxaliplatin, S1 and itraconazole for unresectable pancreatic cancer - Combination chemotherapy with itraconazole for pancreatic cancer
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing sarcomaEUCTR2016-002464-14-ESGrupo Español de Investigación en Sarcomas (GEIS)61
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
招募中
2 期
A Phase II trial of nab-paclitaxel followed by EC as neoadjuvant chemotherapy for resectable breast cancer.breast cancerJPRN-UMIN000017382Tokyo Women's Medical University,Department of endocrine surgery36
已完成
2 期
Phase II clinical study of nab-paclitaxel for patients with recurrent advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000016932The Japan-Multinational Trial Organization (JMTO)81
招募中
不适用
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.Advanced Gastric CancerJPRN-UMIN000015968Tottori University35